Research is exploring the role of A-to-I RNA editing in colon cancer, with studies also investigating its relevance in other types of cancer. The biological and prognostic significance of RNA editing is being examined across various consensus molecular subtypes of cancer. The findings may have implications for understanding cancer pathogenesis, tumor immune evasion, and potential therapeutic targets.